Allurion Technologies (ALUR) announced its intention to initiate a clinical study on the combination of the Allurion Balloon with GLP-1 ...
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.
• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.
Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become ...
The PRAC still has another safety review on the go for the GLP-1 ... side effects that can be caused by Ozempic and Mounjaro (tirzepatide), Lilly’s dual GLP-1/GIP agonist.
Use of the GLP-1 agonist was associated, however, with an increased risk of side effects, particularly gastrointestinal symptoms such as nausea, which occurred in nearly half of patients.